The World Health Organization (WHO) has long identified a critical shortage of eye care professionals, a gap that threatens to undermine public health outcomes for millions of people worldwide. As global populations age and the prevalence of myopia and other refractive errors surges, the traditional model of one-on-one optometric care is facing an existential strain. Piotr Kruszynski, CEO of the diagnostic technology firm Feyenally, recently underscored the gravity of this shortfall, asserting that the current global deficit of optometrists is approximately 40 times the necessary capacity to meet basic demand. According to Kruszynski, the industry has reached a point where traditional human-centric solutions—such as simply training more practitioners—are insufficient to close this widening divide.
The Scale of the Global Eye Care Gap
The burden of uncorrected vision impairment is not distributed equally. According to data from the International Agency for the Prevention of Blindness (IAPB) and the WHO, more than 2.2 billion people globally suffer from near or distance vision impairment. Of these cases, at least 1 billion involve vision impairment that could have been prevented or is yet to be addressed.
The primary barrier to universal access is the concentration of specialized medical labor. In high-income countries, the ratio of optometrists to the general population is relatively robust, though still prone to regional disparities. However, in low- and middle-income regions, the ratio often collapses. In some parts of sub-Saharan Africa and Southeast Asia, there may be fewer than one optometrist for every million people. This structural imbalance ensures that vision correction remains a luxury rather than a public health standard.
Kruszynski’s assessment reflects a growing consensus among health-tech innovators: the scarcity of trained professionals is a structural failure that cannot be remedied through conventional educational pipelines alone. The time required to train a licensed optometrist—often spanning several years of rigorous university-level education—precludes the possibility of a rapid response to the current surge in demand. As the global middle class expands and digital screen usage increases, the rate of myopia progression in children and adults alike is accelerating, further exacerbating the strain on existing eye care systems.
Chronology of a Public Health Challenge
The trajectory of the current optometry shortage can be traced back to the turn of the millennium, as shifting demographic trends began to outpace the graduation rates of medical schools.
- 2000–2010: The rise of global digital adoption leads to a measurable increase in screen-time-related eye strain. During this decade, the first alarms were raised regarding the "myopia epidemic," particularly in East Asian urban centers.
- 2010–2015: WHO initiatives, such as the Universal Eye Health program, begin to categorize vision loss as a major contributor to global economic loss. Despite these initiatives, the supply of qualified optometrists fails to keep pace with the diagnostic needs of an aging global population.
- 2015–2020: The integration of digital health begins to take root. Startups in the diagnostic space begin exploring tele-optometry and remote refraction, though regulatory hurdles and concerns regarding diagnostic accuracy limit widespread adoption.
- 2020–2024: The COVID-19 pandemic serves as an accelerant for remote diagnostics. With physical offices closed or restricted, the necessity for automated, AI-driven eye screening becomes a matter of urgent public policy.
- 2025 and Beyond: The current landscape is defined by a transition toward "AI-as-a-service" models, where companies like Feyenally aim to offload the initial diagnostic burden from human practitioners to machine learning algorithms.
The Technological Pivot: AI as a Force Multiplier
The strategy articulated by Feyenally’s leadership centers on the use of artificial intelligence to perform high-throughput screening, effectively triage patients, and reserve the expertise of human optometrists for complex cases or surgical interventions. By leveraging machine learning models trained on vast datasets of retinal imagery and refractive patterns, companies are developing tools that can be deployed in community centers, pharmacies, and even rural clinics.
This shift represents a fundamental change in the optometric business model. Rather than requiring a specialist to perform every step of the eye examination, AI platforms can now automate the initial refractive assessment and identify early markers of ocular diseases such as diabetic retinopathy, glaucoma, and macular degeneration. Once the AI identifies a potential issue, the system can route the patient to a licensed specialist for a targeted review, thereby optimizing the specialist’s time.
The implications for cost-efficiency are profound. By reducing the time required for a standard screening, the cost per examination drops, making it financially viable to provide screening services in underserved areas. This model effectively democratizes access to vision care, potentially bridging the gap described by Kruszynski by decoupling the diagnostic process from the physical presence of a high-cost specialist.
Analysis of Implications and Market Hurdles
While the technological potential is significant, the integration of AI into clinical optometry is not without challenges. Regulatory frameworks remain the most significant hurdle. Diagnostic AI must satisfy stringent requirements regarding safety, data privacy, and diagnostic accuracy before it can be integrated into national healthcare systems.
Furthermore, the professional optometry community has expressed a range of reactions to these developments. While many recognize the utility of AI as a screening aid, there is a persistent concern regarding the maintenance of high standards of patient care. A recurring question in medical journals is whether the displacement of the "human touch" might lead to a loss of nuanced diagnostic intuition.
However, the prevailing argument from firms like Feyenally is that the alternative—doing nothing—is far worse. If the current trend persists, millions will remain without basic vision correction, leading to significant drops in economic productivity and quality of life. The consensus among health economists is that the "40x" shortage mentioned by Kruszynski requires a systemic overhaul that integrates technology into the clinical workflow.
The Road Ahead: Scalability and Integration
As we look toward the next decade, the scalability of these technologies will determine whether the vision crisis can be stabilized. Key factors that will define the success of this transition include:
- Interoperability: The ability of AI diagnostic systems to feed directly into existing Electronic Health Record (EHR) systems used by traditional optometrists and ophthalmologists.
- Infrastructure: The development of robust, low-bandwidth internet connectivity in rural areas to support cloud-based AI processing.
- Regulatory Harmonization: A global effort to create standardized certification for AI diagnostic tools, ensuring that an algorithm developed in one jurisdiction meets the health safety standards of another.
- Public Trust: Transparent communication regarding how patient data is handled and how AI recommendations are verified by human professionals.
The assertion by Piotr Kruszynski highlights a reality that can no longer be ignored: the traditional education-based supply chain for eye care professionals is broken. The solution, he posits, does not lie in attempting to manufacture more human labor to fill an impossible gap, but in redefining how that labor is utilized. By empowering clinics with AI-driven diagnostic tools, the industry can extend the reach of every qualified optometrist by an order of magnitude.
In conclusion, the optometry sector is undergoing a necessary evolution. The transition from a labor-intensive model to a tech-augmented one is being driven by the sheer necessity of addressing a global public health shortfall. While the path toward universal eye care is fraught with logistical and regulatory complexities, the development of AI-based diagnostic platforms offers the most viable path forward to ensuring that vision, a fundamental human requirement, is accessible to the global population. As the industry continues to iterate on these solutions, the focus will likely remain on maintaining the delicate balance between high-tech efficiency and the high-touch care that remains the hallmark of the medical profession.
